Vaxfab Enterprises board approved preferential allotment of 1,318,550 equity shares at ₹21.02 per share through warrant conversion.
Paid-up equity capital increased to ₹23.52 crore comprising 23,518,577 shares post-allotment.
Eleven investors participated in the conversion, paying ₹15.765 per warrant for equity conversion.
The board meeting was held on April 24, 2026, from 10:10 AM to 10:40 AM.